NCT02356159 2025-09-30Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell TransplantationNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed34 enrolled 18 charts
NCT01233921 2014-04-02Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic CancerFred Hutchinson Cancer CenterPhase NA Completed6 enrolled 7 charts